Kala Pharmaceuticals Inc (KALA)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
9,198,000
EV to revenue ratio (TTM)
0.042
EV to ebitda
-0.158
Financial Performance
Revenue (TTM)
0
Gross profit (TTM)
1,332,000
EBITDA
-24,068,500
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-65.40%
Return on equity (TTM)
-345.30%
Per Share Metrics
Revenue per share (TTM)
0
EPS
-9.39
Diluted EPS (TTM)
-9.39
Book value
0.47
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
0
Price to sales ratio (TTM)
23.75
Price to book ratio (TTM)
1.198
Growth
Quarterly earnings growth (YoY)
-100.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
-2.289